0 Valutazioni
ID

28295

Descrizione

Study ID: 100601 Clinical Study ID: LPL100601 Study Title: LPL100601, A Clinical Outcomes Study of Darapladib versus Placebo in Subjects with Chronic Coronary Heart Disease to Compare the Incidence of Major Adverse Cardiovascular Events (MACE) Patient Level Data: Study Listed on ClinicalStudyDataRequest.com Clinicaltrials.gov Identifier: NCT00799903 Sponsor: GlaxoSmithKline Collaborators: N/A Phase: phase 3 Study Recruitment Status: Completed Generic Name: darapladib Trade Name: darapladib Study Indication: Atherosclerosis Study part: Subject status and major events

Keywords

versioni (4)
  1. 12/10/17 12/10/17 -
  2. 16/10/17 16/10/17 -
  3. 23/10/17 23/10/17 -
  4. 02/01/18 02/01/18 -
Titolare del copyright

GlaxoSmithKline

Caricato su

2 gennaio 2018

DOI

Per favore, per richiedere un accesso.

Licenza

Creative Commons BY-NC 3.0
Commenti del modello :

Puoi commentare il modello dati qui. Tramite i fumetti nei gruppi di articoli e articoli è possibile aggiungere commenti a quelli in modo specifico.

Torna ai commenti del modello
Commenti del gruppo di articoli per :

Commenti dell'articolo per :

  • i più nuovi
  • i più vecchi
  • Popolare
  • i più nuovi
    • i più nuovi
    • i più vecchi
    • Popolare

    Non ci sono commenti

    Per scaricare i modelli di dati devi essere registrato. Per favore accesso o registrati GRATIS.

    Subject status and major events GSK study Chronic Coronary Heart Disease NCT00799903

    Inglese

    Subject status and major events GSK study Chronic Coronary Heart Disease NCT00799903

    1 moduli  
    Subject status and major events
    Descrizione

    Subject status and major events

    1. Has the subject experienced a cardiac endpoint event (MI or UA requiring hospitalization) since the last visit?
    Descrizione

    Yes - complete SAE and MI or ANG endpoint form

    Tipo di dati

    text

    Alias
    UMLS CUI [1]
    C1320716
    2. Has the subject experienced a stroke / TIA event since the last visit?
    Descrizione

    Yes - complete SAE and Stroke/TIA endpoint form

    Tipo di dati

    text

    Alias
    UMLS CUI [1]
    C3844446
    3. Has the subject been hospitalized for heart failure since the last visit?
    Descrizione

    Yes - complete SAE and Hospitalisation for Heart Failure endpoint form

    Tipo di dati

    text

    Alias
    UMLS CUI [1,1]
    C0019993
    UMLS CUI [1,2]
    C0581377
    4. Has the subject undergone a coronary revascularisation since the last visit?
    Descrizione

    Yes - complete SAE and Revascularisation endpoint form

    Tipo di dati

    text

    Alias
    UMLS CUI [1,1]
    C0877341
    UMLS CUI [1,2]
    C1532338
    5. Has the subject been hospitalized for a non-coronary ischemic event since the last visit?
    Descrizione

    Yes - complete SAE and Other Endpoint form

    Tipo di dati

    text

    Alias
    UMLS CUI [1,1]
    C1956346
    UMLS CUI [1,2]
    C0151744
    6. Has the subject undergone a non-coronary revascularisation since the last visit?
    Descrizione

    Yes - complete SAE and Other Endpoint form

    Tipo di dati

    text

    Alias
    UMLS CUI [1,1]
    C0877341
    UMLS CUI [1,2]
    C0543467
    7. Has the subject undergone a limb amputation due to vascular cause since the last visit?
    Descrizione

    Yes - complete SAE and Other Endpoint form

    Tipo di dati

    text

    Alias
    UMLS CUI [1]
    C0002689
    8. Has the subject been diagnosed with new onset diabetes since the last visit?
    Descrizione

    Yes - record details on New Onset Diabetes form, and the Non-Serious Adverse Event or Serious Adverse Event form, as appropriate

    Tipo di dati

    text

    Alias
    UMLS CUI [1,1]
    C0746890
    UMLS CUI [1,2]
    C0011849
    9. Has the subject been diagnosed with new cancer, recurrence of an existing cancer, progression of cancer (=new metastases or new spread) or a benign gastrointestinal polyp(s)/neoplasm(s) since the last visit?
    Descrizione

    Yes - record details on Cancer/GI Neoplasm/Polyp Report form and the Non-Serious Adverse Event or Serious Adverse Event form, as appropriate

    Tipo di dati

    text

    Alias
    UMLS CUI [1]
    C0006826
    10. Has the subject had any GI endoscopic procedures (upper or lower) or GI capsule studies performed since the last time the form was updated?
    Descrizione

    Yes - complete the GI procedures form. Note: If question is being asked for the first time please report GI endoscopic procedure(s) that have been performed from randomization visit until this visit. If question has already been answered at an earlier visit then only refer back to the last time this question was asked.

    Tipo di dati

    text

    Alias
    UMLS CUI [1]
    C0282493
    11. Were any cardiovascular diagnostic procedures that were related to endpoint events performed since the last visit?
    Descrizione

    Yes - record details on the Cardiovascular Diagnostic Procedures form

    Tipo di dati

    text

    Alias
    UMLS CUI [1]
    C0430022
    12. Since the last visit, did the subject experience SAE assessed as related to IP, study participation, or a GSK concomitant medication?
    Descrizione

    Yes - complete Serious Adverse Event form

    Tipo di dati

    text

    Alias
    UMLS CUI [1]
    C1519255
    Ritorna all'inizio della pagina

    Similar models

    Subject status and major events GSK study Chronic Coronary Heart Disease NCT00799903

    1 moduli
    Name
    genere
    Description | Question | Decode (Coded Value)
    Tipo di dati
    Alias
    Item Group
    Subject status and major events
    Item
    1. Has the subject experienced a cardiac endpoint event (MI or UA requiring hospitalization) since the last visit?
    text
    C1320716 (UMLS CUI [1])
    cardiac endpoint event
    Code List
    1. Has the subject experienced a cardiac endpoint event (MI or UA requiring hospitalization) since the last visit?
    CL Item
    Yes (Y)
    CL Item
    No (N)
    CL Item
    Question not asked (Z)
    Item
    2. Has the subject experienced a stroke / TIA event since the last visit?
    text
    C3844446 (UMLS CUI [1])
    cardiac endpoint event
    Code List
    2. Has the subject experienced a stroke / TIA event since the last visit?
    CL Item
    Yes (Y)
    CL Item
    No (N)
    CL Item
    Question not asked (Z)
    Item
    3. Has the subject been hospitalized for heart failure since the last visit?
    text
    C0019993 (UMLS CUI [1,1])
    C0581377 (UMLS CUI [1,2])
    cardiac endpoint event
    Code List
    3. Has the subject been hospitalized for heart failure since the last visit?
    CL Item
    Yes (Y)
    CL Item
    No (N)
    CL Item
    Question not asked (Z)
    Item
    4. Has the subject undergone a coronary revascularisation since the last visit?
    text
    C0877341 (UMLS CUI [1,1])
    C1532338 (UMLS CUI [1,2])
    cardiac endpoint event
    Code List
    4. Has the subject undergone a coronary revascularisation since the last visit?
    CL Item
    Yes (Y)
    CL Item
    No (N)
    CL Item
    Question not asked (Z)
    Item
    5. Has the subject been hospitalized for a non-coronary ischemic event since the last visit?
    text
    C1956346 (UMLS CUI [1,1])
    C0151744 (UMLS CUI [1,2])
    cardiac endpoint event
    Code List
    5. Has the subject been hospitalized for a non-coronary ischemic event since the last visit?
    CL Item
    Yes (Y)
    CL Item
    No (N)
    CL Item
    Question not asked (Z)
    Item
    6. Has the subject undergone a non-coronary revascularisation since the last visit?
    text
    C0877341 (UMLS CUI [1,1])
    C0543467 (UMLS CUI [1,2])
    cardiac endpoint event
    Code List
    6. Has the subject undergone a non-coronary revascularisation since the last visit?
    CL Item
    Yes (Y)
    CL Item
    No (N)
    CL Item
    Question not asked (Z)
    Item
    7. Has the subject undergone a limb amputation due to vascular cause since the last visit?
    text
    C0002689 (UMLS CUI [1])
    cardiac endpoint event
    Code List
    7. Has the subject undergone a limb amputation due to vascular cause since the last visit?
    CL Item
    Yes (Y)
    CL Item
    No (N)
    CL Item
    Question not asked (Z)
    Item
    8. Has the subject been diagnosed with new onset diabetes since the last visit?
    text
    C0746890 (UMLS CUI [1,1])
    C0011849 (UMLS CUI [1,2])
    cardiac endpoint event
    Code List
    8. Has the subject been diagnosed with new onset diabetes since the last visit?
    CL Item
    Yes (Y)
    CL Item
    No (N)
    CL Item
    Question not asked (Z)
    Item
    9. Has the subject been diagnosed with new cancer, recurrence of an existing cancer, progression of cancer (=new metastases or new spread) or a benign gastrointestinal polyp(s)/neoplasm(s) since the last visit?
    text
    C0006826 (UMLS CUI [1])
    cardiac endpoint event
    Code List
    9. Has the subject been diagnosed with new cancer, recurrence of an existing cancer, progression of cancer (=new metastases or new spread) or a benign gastrointestinal polyp(s)/neoplasm(s) since the last visit?
    CL Item
    Yes (Y)
    CL Item
    No (N)
    CL Item
    Question not asked (Z)
    Item
    10. Has the subject had any GI endoscopic procedures (upper or lower) or GI capsule studies performed since the last time the form was updated?
    text
    C0282493 (UMLS CUI [1])
    cardiac endpoint event
    Code List
    10. Has the subject had any GI endoscopic procedures (upper or lower) or GI capsule studies performed since the last time the form was updated?
    CL Item
    Yes (Y)
    CL Item
    No (N)
    CL Item
    Question not asked (Z)
    Item
    11. Were any cardiovascular diagnostic procedures that were related to endpoint events performed since the last visit?
    text
    C0430022 (UMLS CUI [1])
    cardiac endpoint event
    Code List
    11. Were any cardiovascular diagnostic procedures that were related to endpoint events performed since the last visit?
    CL Item
    Yes (Y)
    CL Item
    No (N)
    CL Item
    Question not asked (Z)
    Item
    12. Since the last visit, did the subject experience SAE assessed as related to IP, study participation, or a GSK concomitant medication?
    text
    C1519255 (UMLS CUI [1])
    cardiac endpoint event
    Code List
    12. Since the last visit, did the subject experience SAE assessed as related to IP, study participation, or a GSK concomitant medication?
    CL Item
    Yes (Y)
    CL Item
    No (N)
    CL Item
    Question not asked (Z)
    Ritorna all'inizio della pagina 

    Aiuto

    Do you need help on how to use the search function? Please watch the corresponding tutorial video for more details and learn how to use the search function most efficiently.

    Watch Tutorial